WDR37 and familial pancreatic carcinoma: The results of the clinical cohort further confirmed the strong prognostic value of WDR37, because the overall survival of WDR37-positive pancreatic cancer patients without postoperative chemotherapy was significantly better than that of WDR37-negative pancreatic cancer patients with postoperative chemotherapy.